Sfoglia per AUTORE
LUPPI M
Collezione ASL Asti

  

Items : 5

Health-Related Quality of Life and Symptom Burden Profile of Patients with Pre-Fibrotic and Overt Myelofibrosis: A Preliminary Report from the Gimema-Prophecy Observational Study in Blood

2023
ASL Asti

Caocci G; Palandri F; Loscocco GG; Tieghi A; Patriarca A; Iurlo A; Abruzzese E; Rossi E; Baldi T; Fava C; Beggiato E; Tomasetti S; Marchetti M; Vanni D; Fozza C; Luppi M; La Nasa G; Fazi P; Vignetti M; Vannucchi AM; Efficace F;

Health-Related Quality of Life of Patients with Philadelphia-Negative Myeloproliferative Neoplasms Compared with the General Population: A Preliminary Report from the Gimema Prophecy Study in Blood

2022
ASL Asti

Caocci G; Palandri F; Loscocco GG; Piciocchi A; Iurlo A; Tieghi A; Patriarca A; Abruzzese E; Tomassetti S; Marchetti M; Vanni D; Luppi M; Pane F; Breccia M; Siragusa S; Elli EM; Ricco A; Fozza C; Corsetti MT; Fava C; Mazzoni C; Fazi P; La Nasa G; Vignetti M; Vannucchi AM; Efficace F;

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study. in HemaSphere / Hemasphere. 2020 Jun 8;4(3):e395. doi: 10.1097/HS9.0000000000000395. eCollection 2020 Jun.

2020
ASL Asti
ASL Vercelli

Trentin L; Semenzato G; Marasca R; Cuneo A; Luppi M; Bassan R; Krampera M; Marinello S; Piazza F; Gherlinzoni F; Riva M; Briani C; Cibien F; Rigolin GM; Paolini R; Sancetta R; Ferrarini I; Marchetti M; Nasillo V; Visentin A;

Pretreatment health-related quality of life profile according to the eortc QLQ-C30 in patients with myelodysplastic syndromes (MDS): Analysis on 443 lower-risk MDS patients in Blood

2018
ASL Asti

Efficace F; Ricco A; Breccia M; Frairia C; Fianchi L; Sanpaolo G; Crugnola M; Invernizzi R; Luppi M; Stauder R; Petranovic D; Platzbecker U; Caocci G; Fedele M; Palumbo GA; Cottone F; Patriarca A; Niscola P; Karakantza M; Vignetti M; Canicattì M; Zhang H; Di Renzo N; Cuneo A; Kyriakou C; Voso MT; Fozza C; Santini V; Caers J; et alii...

Impact of transfusion dependency on health-related quality of life outcomes in newly diagnosed patients with myelodysplastic syndromes (MDS). Analysis on 669 patients by disease risk in Blood

2017
ASL Asti

Niscola P; Efficace F; Borin LM; Bergamaschi M; Invernizzi R; Cottone F; Canicattì M; Okumura I; Allione B; Vallisa D; Voso MT; Palumbo GA; Breccia M; Gaidano G; Ricco A; Caocci G; Mandelli F; Vignetti M; Cascavilla N; Caers J; Petranovic D; Luppi M; Platzbecker U; Stauder R; Zhang H; Angela Di Tucci A;